Parallel Advisors »

Xenon Pharmaceuticals shares owned by Parallel Advisors

Quarter-by-quarter ownership of Xenon Pharmaceuticals (XENE) shares owned by Parallel Advisors from 13F filings

Historical chart of Parallel Advisors investment in Xenon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xenon Pharmaceuticals held by Parallel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xenon Pharmaceuticals by Parallel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $52k 1.1k 46.06
2023-09-30 $25k 744 34.16
2023-06-30 $30k 776 38.50

More positions owned by Parallel Advisors

Ishares Core S&p Total U.s. Stock Market Etf Etf (ITOT)
Ishares S&p 500 Index Etf (IVV)
Apple Stock (AAPL)
Corcept Therapeutics Stock (CORT)
Ishares Msci Usa Quality Factor Etf Etf (QUAL)
Microsoft Stock (MSFT)
Cvb Finl Corp Stock (CVBF)
Nvidia Corp Stock (NVDA)
Ishares Core Msci Eafe Etf Etf (IEFA)
Vanguard Large Cap Etf (VV)
Amazon.com Stock (AMZN)
Ishares Tr Lehman Short Trea Bd Etf (SHV)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Ishares Aggregate Bond Etf Etf (AGG)
Vanguard Small Cap Etf Etf (VB)

View all positions for Parallel Advisors

Top funds holding Xenon Pharmaceuticals

venBio Select Advisor
Wellington Management Company
Commodore Capital
Paradigm Biocapital Advisors
Braidwell
First Light Asset Management
Alliancebernstein
Marshall Wace
Citadel Advisors
Perceptive Advisors
Baker Bros. Advisors
Henderson Group
BVF
Point72 Asset Management
Avidity Partners Management

View all funds holding Xenon Pharmaceuticals